Gap junctions and connexins as therapeutic targets in cancer

Expert Opinion on Therapeutic Targets

Volumn 14, Issue 7, 2010, Pages 681-692

  Kandouz, Mustapha ^a   Batist, Gerald ^b  

^a WAYNE STATE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b MCGILL UNIVERSITY   (Canada)

Author keywords

Bystander effect; Cancer; Chemosensitization; Connexin; Gap junction

Indexed keywords

4 AMINO 5 (4 CHLOROPHENYL) 7 (TERT BUTYL)PYRAZOLO[3,4 D]PYRAMIDINE; 4 PHENYLBUTYRIC ACID; 5 AZA 2' DEOXYCYTIDINE; ALPHA GLYCYRREHETINIC ACID; ANTHRA[1,9 CD]PYRAZOL 6(2H) ONE; ATRASENTAN; BENZYLOXYCARBONYLLEUCYLLEUCYLLEUCINAL; BREFELDIN A; BUTYRIC ACID; CARBENOXOLONE; CARMUSTINE; CISPLATIN; CYCLO(DEXTRO TRYPTOPHYL DEXTRO ASPARTYLPROLYL DEXTRO VALYLLEUCYL); DOCETAXEL; DOXORUBICIN; ETOPOSIDE; GAP JUNCTION PROTEIN; GEMCITABINE; MELPHALAN; NAVELBINE; PACLITAXEL; PROTEIN INHIBITOR; PROTEIN TYROSINE KINASE INHIBITOR; QUINOLINE DERIVATIVE; QUINOLINE PQ1; TAMOXIFEN; TRICHOSTATIN A; TYRPHOSTIN; TYRPHOSTIN 25; UNCLASSIFIED DRUG; VINBLASTINE; ANTINEOPLASTIC AGENT; CONNEXIN 43; MICRORNA; TUMOR MARKER;

ANTINEOPLASTIC ACTIVITY; APOPTOSIS; BYSTANDER EFFECT; CARCINOGENESIS; CHEMOSENSITIZATION; DRUG POTENTIATION; DRUG TARGETING; GENE THERAPY; HUMAN; KIDNEY CARCINOMA; METASTASIS; NONHUMAN; PROTEIN DEGRADATION; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN MODIFICATION; PROTEIN PHOSPHORYLATION; REVIEW; SIGNAL TRANSDUCTION; SUICIDE GENE THERAPY; TRANSCRIPTION REGULATION; TUMOR CELL; TUMOR MICROENVIRONMENT; UBIQUITINATION; AGONISTS; ANIMAL; ANTAGONISTS AND INHIBITORS; CELL COMMUNICATION; DRUG EFFECTS; GAP JUNCTION; GENE EXPRESSION REGULATION; GENETICS; METABOLISM; NEOPLASM METASTASIS; NEOPLASMS; PATHOPHYSIOLOGY; PHYSIOLOGY; PROTEIN PROCESSING;

ANIMALS; ANTINEOPLASTIC AGENTS; APOPTOSIS; BYSTANDER EFFECT; CELL COMMUNICATION; CONNEXIN 43; CONNEXINS; GAP JUNCTIONS; GENE EXPRESSION REGULATION, NEOPLASTIC; GENE THERAPY; HUMANS; MICRORNAS; NEOPLASM METASTASIS; NEOPLASMS; PROTEIN PROCESSING, POST-TRANSLATIONAL; TUMOR MARKERS, BIOLOGICAL; GENETIC THERAPY;

EID: 77953585288     PISSN: 14728222     EISSN: None     Source Type: Journal    
DOI: 10.1517/14728222.2010.487866     Document Type: Review

References (97)

1. Wei CJ, Xu X, Lo CW. Connexins and cell signaling in development and disease. Annu Rev Cell Dev Biol 2004;20:811-838
2. Yeager M, Harris AL. Gap junction channel structure in the early 21st century: facts and fantasies. Curr Opin Cell Biol 2007;19:521-528
3. Solan JL, Lampe PD. Connexin43 phosphorylation: structural changes and biological effects. Biochem J 2009;419:261-272
4. Laird DW, Fistouris P, Batist G, et al. Deficiency of connexin43 gap junctions is an independent marker for breast tumors. Cancer Res 1999;59:4104-4110
5. Tsai H, Werber J, Davia MO, et al. Reduced connexin 43 expression in high grade, human prostatic adenocarcinoma cells. Biochem Biophys Res Commun 1996;227:64-69
6. Mesnil M, Crespin S, Avanzo JL, Zaidan-Dagli ML. Defective gap junctional intercellular communication in the carcinogenic process. Biochim Biophys Acta 2005;1719:125-145
7. Brissette JL, Kumar NM, Gilula NB, Dotto GP. The tumor promoter 12-Otetradecanoylphorbol- 13-acetate and the ras oncogene modulate expression and phosphorylation of gap junction proteins. Mol Cell Biol 1991;11:5364-5371
8. Leithe E, Rivedal E. Epidermal growth factor regulates ubiquitination, internalization and proteasome-dependent degradation of connexin43. J Cell Sci 2004;117:1211-1220
9. Tai MH, Upham BL, Olson LK, et al. Cigarette smoke components inhibited intercellular communication and differentiation in human pancreatic ductal epithelial cells. Int J Cancer 2007;120:1855-1862
10. Peterson-Roth E, Brdlik CM, Glazer PM. Src-Induced cisplatin resistance mediated by cell-to-cell communication. Cancer Res 2009;69:3619-3624
11. Fernstrom MJ, Koffler LD, bou-Rjaily G, et al. Neoplastic reversal of human ovarian carcinoma cells transfected with connexin43. Exp Mol Pathol 2002;73:54-60
12. Dbouk HA, Mroue RM, El-Sabban ME, Talhouk RS. Connexins: a myriad of functions extending beyond assembly of gap junction channels. Cell Commun Signal 2009;7:4: published online 12 March 2009, doi:10.1186/1478-811X-7-4
13. McLachlan E, Shao Q, Laird DW. Connexins and gap junctions in mammary gland development and breast cancer progression. J Membr Biol 2007;218:107-121
14. Ito A, Koma Y, Uchino K, et al. Increased expression of connexin 26 in the invasive component of lung squamous cell carcinoma: significant correlation with poor prognosis. Cancer Lett 2006;234:239-248
15. McLachlan E, Shao Q, Wang HL, et al. Connexins act as tumor suppressors in three-dimensional mammary cell organoids by regulating differentiation and angiogenesis. Cancer Res 2006;66:9886-9894
16. Elzarrad MK, Haroon A, Willecke K, et al. Connexin-43 upregulation in micrometastases and tumor vasculature and its role in tumor cell attachment to pulmonary endothelium. BMC Med 2008;6:20: published online 22 July 2008, doi:10.1186/1741-7015-6-20
17. Ito A, Katoh F, Kataoka TR, et al. A role for heterologous gap junctions between melanoma and endothelial cells in metastasis. J Clin Invest 2000;105:1189-1197
18. Li Z, Zhou Z, Donahue HJ. Alterations in Cx43 and OB-cadherin affect breast cancer cell metastatic potential. Clin Exp Metastasis 2008;25:265-272
19. Li Z, Zhou Z, Welch DR, Donahue HJ. Expressing connexin 43 in breast cancer cells reduces their metastasis to lungs. Clin Exp Metastasis 2008;25:893-901
20. Kanczuga-Koda L, Sulkowski S, Lenczewski A, et al. Increased expression of connexins 26 and 43 in lymph node metastases of breast cancer. J Clin Pathol 2006;59:429-433
21. Moharita AL, Taborga M, Corcoran KE, et al. SDF-1alpha regulation in breast cancer cells contacting bone marrow stroma is critical for normal hematopoiesis. Blood 2006;108:3245-3252
22. van Dillen IJ, Mulder NH, Vaalburg W, et al. Influence of the bystander effect on HSV-tk/GCV gene therapy. A review. Curr Gene Ther 2002;2:307-322
23. Prise KM, O'Sullivan JM. Radiation-induced bystander signalling in cancer therapy. Nat Rev Cancer 2009;9:351-360
24. McMasters RA, Saylors RL, Jones KE, et al. Lack of bystander killing in herpes simplex virus thymidine kinase-transduced colon cell lines due to deficient connexin43 gap junction formation. Hum Gene Ther 1998;9:2253-2261
25. Elshami AA, Saavedra A, Zhang H, et al. Gap junctions play a role in the 'bystander effect' of the herpes simplex virus thymidine kinase/ganciclovir system in vitro. Gene Ther 1996;3:85-92
26. Carystinos GD, Katabi MM, Laird DW, et al. Cyclic-AMP induction of gap junctional intercellular communication increases bystander effect in suicide gene therapy. Clin Cancer Res 1999;5:61-68
27. Mothersill C, Seymour CB. Radiation-induced bystander effects-implications for cancer. Nat Rev Cancer 2004;4:158-164
28. Tanaka T, Yamasaki H, Mesnil M. Induction of a bystander effect in HeLa cells by using a bigenic vector carrying viral thymidine kinase and connexin32 genes. Mol Carcinog 2001;30:176-180
29. Azzam EI, de Toledo SM, Little JB. Direct evidence for the participation of gap junction-mediated intercellular communication in the transmission of damage signals from alpha-particle irradiated to nonirradiated cells. Proc Natl Acad Sci USA 2001;98:473-478
30. King TJ, Bertram JS. Connexins as targets for cancer chemoprevention and chemotherapy. Biochim Biophys Acta 2005;1719:146-160
31. le-Agha N, Stahl W, Sies H. (-)-Epicatechin effects in rat liver epithelial cells: stimulation of gap junctional communication and counteraction of its loss due to the tumor promoter 12-O-tetradecanoylphorbol-13-acetate. Biochem Pharmacol 2002;63:2145-2149
32. Zhang LX, Cooney RV, Bertram JS. Carotenoids enhance gap junctional communication and inhibit lipid peroxidation in C3H/10T1/2 cells: relationship to their cancer chemopreventive action. Carcinogenesis 1991;12:2109-2114
33. Nielsen M, Ruch RJ, Vang O. Resveratrol reverses tumor-promoter-induced inhibition of gap-junctional intercellular communication. Biochem Biophys Res Commun 2000;275:804-809
34. Carystinos GD, Alaoui-Jamali MA, Phipps J, et al. Upregulation of gap junctional intercellular communication and connexin 43 expression by cyclic-AMP and all-trans-retinoic acid is associated with glutathione depletion and chemosensitivity in neuroblastoma cells. Cancer Chemother Pharmacol 2001;47:126-132
35. Sato H, Senba H, Virgona N, et al. Connexin 32 potentiates vinblastine-induced cytotoxicity in renal cell carcinoma cells. Mol Carcinog 2007;46:215-224 (Pubitemid 46399520)
36. Westhoff MA, Zhou S, Bachem MG, et al. Identification of a novel switch in the dominant forms of cell adhesion-mediated drug resistance in glioblastoma cells. Oncogene 2008;27:5169-5181
37. Huang RP, Hossain MZ, Huang R, et al. Connexin 43 (cx43) enhances chemotherapy-induced apoptosis in human glioblastoma cells. Int J Cancer 2001;92:130-138 (Pubitemid 32187042)
38. Fukushima M, Hattori Y, Yoshizawa T, Maitani Y. Combination of non-viral connexin 43 gene therapy and docetaxel inhibits the growth of human prostate cancer in mice. Int J Oncol 2007;30:225-231
39. Wang M, Berthoud VM, Beyer EC. Connexin43 increases the sensitivity of prostate cancer cells to TNFalpha-induced apoptosis. J Cell Sci 2007;120:320-329
40. Gakhar G, Hua DH, Nguyen TA. Combinational treatment of gap junctional activator and tamoxifen in breast cancer cells. Anticancer Drugs 2010;21:77-88
41. Huynh HT, Alpert L, Laird DW, et al. Regulation of the gap junction connexin 43 gene by androgens in the prostate. J Mol Endocrinol 2001;26:1-10
42. Escobar A, Lopez M, Serrano A, et al. Dendritic cell immunizations alone or combined with low doses of interleukin-2 induce specific immune responses in melanoma patients. Clin Exp Immunol 2005;142:555-568
43. Mendoza-Naranjo A, Saez PJ, Johansson CC, et al. Functional gap junctions facilitate melanoma antigen transfer and cross-presentation between human dendritic cells. J Immunol 2007;178:6949-6957
44. Li J, Wood WH III, Becker KG, et al. Gene expression response to cisplatin treatment in drug-sensitive and drug-resistant ovarian cancer cells. Oncogene 2007;26:2860-2872
45. Ito A, Morita N, Miura D, et al. A derivative of oleamide potently inhibits the spontaneous metastasis of mouse melanoma BL6 cells. Carcinogenesis 2004;25:2015-2022
46. Cusato K, Ripps H, Zakevicius J, Spray DC. Gap junctions remain open during cytochrome c-induced cell death: relationship of conductance to 'bystander' cell killing. Cell Death Differ 2006;13:1707-1714
47. Peixoto PM, Ryu SY, Pruzansky DP, et al. Mitochondrial apoptosis is amplified through gap junctions. Biochem Biophys Res Commun 2009;390:38-43
48. Jensen R, Glazer PM. Cell-interdependent cisplatin killing by Ku/DNA-dependent protein kinase signaling transduced through gap junctions. Proc Natl Acad Sci USA 2004;101:6134-6139
49. Neijssen J, Herberts C, Drijfhout JW, et al. Cross-presentation by intercellular peptide transfer through gap junctions. Nature 2005;434:83-88
50. Pang B, Neijssen J, Qiao X, et al. Direct antigen presentation and gap junction mediated cross-presentation during apoptosis. J Immunol 2009;183:1083-1090
51. Trepel M, Stoneham CA, Eleftherohorinou H, et al. A heterotypic bystander effect for tumor cell killing after adeno-associated virus/phagemediated, vascular-targeted suicide gene transfer. Mol Cancer Ther 2009;8:2383-2391
52. Benlalam H, Jalil A, Hasmim M, et al. Gap junction communication between autologous endothelial and tumor cells induce cross-recognition and elimination by specific CTL. J Immunol 2009;182:2654-2664
53. Seul KH, Kang KY, Lee KS, et al. Adenoviral delivery of human connexin37 induces endothelial cell death through apoptosis. Biochem Biophys Res Commun 2004;319:1144-1151
54. Huang Q, Liu XZ, Kang CS, et al. The anti-glioma effect of suicide gene therapy using BMSC expressing HSV/TK combined with overexpression of Cx43 in glioma cells. Cancer Gene Ther 2010;17:192-202
55. Matuskova M, Hlubinova K, Pastorakova A, et al. HSV-tk expressing mesenchymal stem cells exert bystander effect on human glioblastoma cells. Cancer Lett 2010;290:58-67
56. Kapoor P, Saunders MM, Li Z, et al. Breast cancer metastatic potential: correlation with increased heterotypic gap junctional intercellular communication between breast cancer cells and osteoblastic cells. Int J Cancer 2004;111:693-697
57. Presley CA, Lee AW, Kastl B, et al. Bone marrow connexin-43 expression is critical for hematopoietic regeneration after chemotherapy. Cell Commun Adhes 2005;12:307-317
58. Paraguassu-Braga FH, Borojevic R, Bouzas LF, et al. Bone marrow stroma inhibits proliferation and apoptosis in leukemic cells through gap junction-mediated cell communication. Cell Death Differ 2003;10:1101-1108
59. Qin H, Shao Q, Curtis H, et al. Retroviral delivery of connexin genes to human breast tumor cells inhibits in vivo tumor growth by a mechanism that is independent of significant gap junctional intercellular communication. J Biol Chem 2002;277:29132-29138
60. Huang RP, Fan Y, Hossain MZ, et al. Reversion of the neoplastic phenotype of human glioblastoma cells by connexin 43 (cx43). Cancer Res 1998;58:5089-5096
61. Omori Y, Yamasaki H. Mutated connexin43 proteins inhibit rat glioma cell growth suppression mediated by wild-type connexin43 in a dominant-negative manner. Int J Cancer 1998;78:446-453
62. Goodenough DA, Paul DL. Beyond the gap: functions of unpaired connexon channels. Nat Rev Mol Cell Biol 2003;4:285-294
63. Evans WH, De VE, Leybaert L. The gap junction cellular internet: connexin hemichannels enter the signalling limelight. Biochem J 2006;397:1-14
64. Decrock E, De VE, Vinken M, et al. Connexin 43 hemichannels contribute to the propagation of apoptotic cell death in a rat C6 glioma cell model. Cell Death Differ 2009;16:151-163
65. Dai P, Nakagami T, Tanaka H, et al. Cx43 mediates TGF-beta signaling through competitive Smads binding to microtubules. Mol Biol Cell 2007;18:2264-2273
66. Geimonen E, Jiang W, Ali M, et al. Activation of protein kinase C in human uterine smooth muscle induces connexin-43 gene transcription through an AP-1 site in the promoter sequence. J Biol Chem 1996;271:23667-23674
67. Carystinos GD, Kandouz M, Alaoui-Jamali MA, Batist G. Unexpected induction of the human connexin 43 promoter by the ras signaling pathway is mediated by a novel putative promoter sequence. Mol Pharmacol 2003;63:821-831
68. Ammerpohl O, Trauzold A, Schniewind B, et al. Complementary effects of HDAC inhibitor 4-PB on gap junction communication and cellular export mechanisms support restoration of chemosensitivity of PDAC cells. Br J Cancer 2007;96:73-81
69. Ammerpohl O, Thormeyer D, Khan Z, et al. HDACi phenylbutyrate increases bystander killing of HSV-tk transfected glioma cells. Biochem Biophys Res Commun 2004;324:8-14
70. Hernandez M, Shao Q, Yang XJ, et al. A histone deacetylation-dependent mechanism for transcriptional repression of the gap junction gene cx43 in prostate cancer cells. Prostate 2006;66:1151-1161
71. Jung JW, Cho SD, Ahn NS, et al. Effects of the histone deacetylases inhibitors sodium butyrate and trichostatin A on the inhibition of gap junctional intercellular communication by. Cancer Lett 2006;241:301-308
72. Hagiwara H, Sato H, Ohde Y, et al. 5-Aza-2¢-deoxycytidine suppresses human renal carcinoma cell growth in a xenograft model via up-regulation of the connexin 32 gene. Br J Pharmacol 2008;153:1373-1381
73. Gao FH, Wang Q, Wu YL, et al. c-Jun N-terminal kinase mediates AML1-ETO protein-induced connexin-43 expression. Biochem Biophys Res Commun 2007;356:505-511
74. Villares GJ, Dobroff AS, Wang H, et al. Overexpression of protease-activated receptor-1 contributes to melanoma metastasis via regulation of connexin 43. Cancer Res 2009;69:6730-6737
75. Leithe E, Rivedal E. Ubiquitination of gap junction proteins. J Membr Biol 2007;217:43-51
76. Huang T, Zhu Y, Fang X, et al. Gap junctions sensitize cancer cells to proteasome inhibitor MG132-induced apoptosis. Cancer Sci 2010;101:713-721
77. Pahujaa M, Anikin M, Goldberg GS. Phosphorylation of connexin43 induced by Src: regulation of gap junctional communication between transformed cells. Exp Cell Res 2007;313:4083-4090
78. Nakamura Y, Chang CC, Mori T, et al. Augmentation of differentiation and gap junction function by kaempferol in partially differentiated colon cancer cells. Carcinogenesis 2005;26:665-671
79. Spinella F, Rosano L, Di Castro V, et al. Endothelin-1 decreases gap junctional intercellular communication by inducing phosphorylation of connexin 43 in human ovarian carcinoma cells. J Biol Chem 2003;278:41294-41301
80. Lahlou H, Fanjul M, Pradayrol L, et al. Restoration of functional gap junctions through internal ribosome entry site-dependent synthesis of endogenous connexins in density-inhibited cancer cells. Mol Cell Biol 2005;25:4034-4045
81. Garzon R, Calin GA, Croce CM. MicroRNAs in cancer. Annu Rev Med 2009;60:167-179
82. Anderson C, Catoe H, Werner R. MIR-206 regulates connexin43 expression during skeletal muscle development. Nucleic Acids Res 2006;34:5863-5871
83. Yang B, Lin H, Xiao J, et al. The muscle-specific microRNA miR-1 regulates cardiac arrhythmogenic potential by targeting GJA1 and KCNJ2. Nat Med 2007;13:486-491
84. Kedde M, Strasser MJ, Boldajipour B, et al. RNA-binding protein Dnd1 inhibits microRNA access to target mRNA. Cell 2007;131:1273-1286
85. Krutzfeldt J, Rajewsky N, Braich R, et al. Silencing of microRNAs in vivo with 'antagomirs'. Nature 2005;438:685-689
86. Kandouz M, Bier A, Carystinos GD, et al. Connexin43 pseudogene is expressed in tumor cells and inhibits growth. Oncogene 2004;23:4763-4770
87. Bier A, Oviedo-Landaverde I, Zhao J, et al. Connexin43 pseudogene in breast cancer cells offers a novel therapeutic target. Mol Cancer Ther 2009;8:786-793
88. Jin C, Lau AF, Martyn KD. Identification of connexin-interacting proteins: application of the yeast two-hybrid screen. Methods 2000;20:219-231
89. Carette D, Gilleron J, Decrouy X, et al. Connexin 33 impairs gap junction functionality by accelerating connexin 43 gap junction plaque endocytosis. Traffic 2009;10:1272-1285
90. Qu C, Gardner P, Schrijver I. The role of the cytoskeleton in the formation of gap junctions by Connexin 30. Exp Cell Res 2009;315:1683-1692
91. Sato H, Iwata H, Takano Y, et al. Enhanced effect of connexin 43 on cisplatin-induced cytotoxicity in mesothelioma cells. J Pharmacol Sci 2009;110:466-475
92. Hattori Y, Fukushima M, Maitani Y. Non-viral delivery of the connexin 43 gene with histone deacetylase inhibitor to human nasopharyngeal tumor cells enhances gene expression and inhibits in vivo tumor growth. Int J Oncol 2007;30:1427-1439
93. Sato H, Fukumoto K, Hada S, et al. Enhancing effect of connexin 32 gene on vinorelbine-induced cytotoxicity in A549 lung adenocarcinoma cells. Cancer Chemother Pharmacol 2007;60:449-457
94. Tanaka M, Grossman HB. Connexin 26 gene therapy of human bladder cancer: induction of growth suppression, apoptosis, and synergy with Cisplatin. Hum Gene Ther 2001;12:2225-2236
95. Tanaka M, Grossman HB. Connexin 26 induces growth suppression, apoptosis and increased efficacy of doxorubicin in prostate cancer cells. Oncol Rep 2004;11:537-541
96. Thomas T, Jordan K, Simek J, et al. Mechanisms of Cx43 and Cx26 transport to the plasma membrane and gap junction regeneration. J Cell Sci 2005;118:4451-4462
97. Piehl M, Lehmann C, Gumpert A, et al. Internalization of large double-membrane intercellular vesicles by a clathrin-dependent endocytic process. Mol Biol Cell 2007;18:337-347